Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 43
Filter
Add more filters










Publication year range
1.
J Neural Transm (Vienna) ; 108(10): 1127-34, 2001.
Article in English | MEDLINE | ID: mdl-11725815

ABSTRACT

Basigin (Bsg) is a transmembrane glycoprotein belonging to the immunoglobulin superfamily and widely expressed in the central nervous system. To elucidate functional role of Bsg in the central nervous system, the effects of its glutathione-S-transferase (GST) fusion protein on the number and neurite outgrowth of cultured rat mesencephalic dopaminergic neurons were measured. The fusion protein was not able to promote the survival and neurite outgrowth of tyrosine hydroxylase (TH)-positive neurons under serum-free condition. However, the treatment of 1-methyl-4-phenylpyridinium (MPP+)-exposed cultures with the fusion protein resulted in stimulation of the regrowth of damaged TH-positive fibers. Basic fibroblast growth factor (bFGF) also stimulated the regrowth of neurites in damaged neurons. These results indicate that Bsg may play an important role in the regrowth of damaged dopaminergic fibers.


Subject(s)
1-Methyl-4-phenylpyridinium/toxicity , Antigens, CD , Antigens, Neoplasm , Antigens, Surface , Avian Proteins , Blood Proteins , Dopamine , Membrane Glycoproteins/pharmacology , Mesencephalon/cytology , Mesencephalon/drug effects , Nerve Fibers/drug effects , Animals , Basigin , Cell Division/drug effects , Cells, Cultured , Dopamine/physiology , Embryo, Mammalian , Herbicides/pharmacology , Humans , Mesencephalon/physiology , Nerve Fibers/pathology , Rats , Rats, Sprague-Dawley
2.
Carcinogenesis ; 22(3): 515-7, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11238194

ABSTRACT

Several reports have noted epidemiological differences in the prevalence or prognostic significance of p53 mutants with arginine (R) or proline (P) at the codon 72 polymorphism (R72/P72) in certain cancer types, but the biological significance of these variants is unclear. The ability of p53 mutants to interact with and inactivate the p53 homolog p73 was recently reported to depend on the conformational state of the p53 protein and the residue at codon 72. Since the conformation of p53 mutants may influence their ability to transdominantly inhibit wild-type p53, we tested whether there was a correlation between the amino acid at codon 72 and the transdominance of p53 alleles found in tumors. The transdominance test was performed using a simple yeast transcription assay, and the amino acid at codon 72 was determined by sequencing. A total of 100 p53 mutants were tested. Compared with the germline frequency (R:P = 427:297), an extreme bias in favor of the R72 allele was observed with recessive mutants (R:P = 50:7, P < 0.0002), whereas no selection for the R72 allele was seen with transdominant mutants (R:P = 23:20). p53 and p73 are known to transactivate overlapping sets of target genes. We interpret the R72 bias with recessive mutants as evidence that decreased activation of p53 target genes provides a selective growth advantage to tumor cells during the stage of tumorigenesis in which a wild-type and mutant p53 allele coexist. We suggest that transdominant p53 mutants achieve this by inactivation of the remaining wild-type p53 allele, whereas recessive p53 mutants achieve it through inactivation of p73.


Subject(s)
Alleles , Arginine/genetics , Genes, Dominant , Mutation , Neoplasms/genetics , Polymorphism, Genetic , Tumor Suppressor Protein p53/genetics , Humans , Tumor Suppressor Protein p53/chemistry
3.
Genomics ; 67(2): 146-52, 2000 Jul 15.
Article in English | MEDLINE | ID: mdl-10903839

ABSTRACT

We have identified a novel mammalian gene, TMEFF2, that encodes a putative transmembrane protein containing two follistatin-like domains and one epidermal growth factor (EGF)-like domain. The TMEFF2 gene is predominantly expressed in the brain. In situ hybridization analysis revealed that TMEFF2 is widely expressed in the brain, including hippocampal cornu ammonis, dentate gyrus, and substantia nigra pars compacta. We evaluated the survival effect of TMEFF2 using primary cultured neurons from several regions of fetal rat brain following treatment with a recombinant TMEFF2 protein fragment consisting of the putative extracellular domain. TMEFF2 increased survival of neurons from the hippocampus and midbrain, but not from the cerebral cortex, indicating that the survival effects of TMEFF2 are specific to certain cell types. Recombinant TMEFF2 also promoted survival of mesencephalic dopaminergic neurons. Together, these findings suggest that TMEFF2 may be a novel survival factor for hippocampal and mesencephalic, but not for cortical, neurons.


Subject(s)
Hippocampus/metabolism , Membrane Proteins/genetics , Mesencephalon/metabolism , Neurons/metabolism , Amino Acid Sequence , Animals , Blotting, Northern , Brain/metabolism , Cell Survival , Cells, Cultured , Cloning, Molecular , DNA, Complementary/chemistry , DNA, Complementary/genetics , Epidermal Growth Factor/genetics , Female , Fetus , Gene Expression , Hippocampus/cytology , Humans , Male , Mesencephalon/cytology , Mice , Mice, Inbred C57BL , Mice, Inbred Strains , Molecular Sequence Data , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Sequence Alignment , Sequence Analysis, DNA , Sequence Homology, Amino Acid , Tissue Distribution
4.
Genomics ; 65(2): 166-73, 2000 Apr 15.
Article in English | MEDLINE | ID: mdl-10783264

ABSTRACT

The HNK-1 carbohydrate is expressed on various cell adhesion molecules in the nervous system and is suggested to play a role in cell-cell and cell-substrate interactions. Here we describe the isolation of a cDNA encoding human glucuronyltransferase (GlcAT-P), which is a key enzyme in the biosynthesis of the HNK-1 carbohydrate. The primary structure deduced from the cDNA sequence predicted a type II transmembrane protein of 334 amino acids. Human GlcAT-P was 98.2% identical with rat GlcAT-P in amino acid sequence, the exception being the length of the cytoplasmic tail. Northern blot analysis indicated that human GlcAT-P is expressed mainly in the brain. There is a single copy of the human GlcAT-P gene (HGMW-approved symbol B3GAT1), and it was mapped to chromosome 11q25.


Subject(s)
CD57 Antigens/biosynthesis , Chromosome Mapping , Cloning, Molecular , Glucuronosyltransferase/genetics , Amino Acid Sequence , Animals , Base Sequence , Blotting, Northern , Blotting, Southern , Brain , Chromosomes, Human, Pair 11 , DNA, Complementary/biosynthesis , Expressed Sequence Tags , Gene Dosage , Humans , Molecular Sequence Data , Protein Conformation , RNA, Messenger/metabolism , Rats , Sequence Homology, Amino Acid , Tissue Distribution
5.
J Cereb Blood Flow Metab ; 19(12): 1336-44, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10598938

ABSTRACT

To examine a possible protective effect of exogenous glial cell line-derived neurotrophic factor (GDNF) gene expression against ischemic brain injury, a replication-defective adenoviral vector containing GDNF gene (Ad-GDNF) was directly injected into the cerebral cortex at 1 day before 90 minutes of transient middle cerebral artery occlusion (MCAO) in rats. 2,3,5-Triphenyltetrazolium chloride staining showed that infarct volume of the Ad-GDNF-injected group at 24 hours after the transient MCAO was significantly smaller than that of vehicle- or Ad-LacZ-treated group. Enzyme-linked immunosorbent assay (ELISA) for immunoreactive GDNF demonstrated that GDNF gene products in the Ad-GDNF-injected group were higher than those of vehicle-treated group at 24 hours after transient MCAO. Immunoreactive GDNF staining was obviously detected in the cortex around the needle track just before or 24 hours after MCAO in the Ad-GDNF group, whereas no or slight GDNF staining was detected in the vehicle group. The numbers of TUNEL, immunoreactive caspase-3, and cytochrome c-positive neurons induced in the ipsilateral cerebral cortex at 24 hours after transient MCAO were markedly reduced by the Ad-GDNF group. These results suggest that the successful exogenous GDNF gene transfer ameliorates ischemic brain injury after transient MCAO in association with the reduction of apoptotic signals.


Subject(s)
Brain/pathology , Gene Transfer Techniques , Ischemic Attack, Transient/pathology , Ischemic Attack, Transient/physiopathology , Nerve Growth Factors , Nerve Tissue Proteins/physiology , Adenoviruses, Human , Animals , Cell Line , Cerebral Cortex , Genetic Vectors , Glial Cell Line-Derived Neurotrophic Factor , Humans , Ischemic Attack, Transient/therapy , Male , Middle Cerebral Artery , Nerve Tissue Proteins/analysis , Nerve Tissue Proteins/genetics , Rats , Rats, Wistar , Recombinant Proteins/analysis , Reperfusion , Time Factors
6.
Neurosci Lett ; 274(1): 45-8, 1999 Oct 15.
Article in English | MEDLINE | ID: mdl-10530516

ABSTRACT

In order to clarify the role of protein kinases in ischemic brain injury, the spatiotemporal expression of immunoreactive serine-threonine kinase Akt, phosphatidylinositol 3-kinase (PI3-K) and extracellular signal-regulated kinase (ERK) were examined at 3, 8, or 24 h after permanent middle cerebral artery occlusion (MCAO) in rats. Weak staining for these protein kinases was found in both cortical and caudate neurons in sham controls. The staining for Akt-1 and PI3-K was increased at 3-8 h in the ischemic penumbral region and declined at 24 h. A slight induction of these kinases was observed in the ischemic core region. Robust expression of ERK was noted at 3-8 h in most neurons in the area of ischemia. At 24 h, ERK continued to be expressed in the ischemic penumbra, but decreased in the ischemic core. These findings suggest that the signaling for Akt and PI3-K are different from the ERK dependent signal transduction during ischemic brain injury.


Subject(s)
Brain Ischemia/enzymology , Caudate Nucleus/enzymology , Cerebral Cortex/enzymology , Mitogen-Activated Protein Kinases/biosynthesis , Phosphatidylinositol 3-Kinases/biosynthesis , Proto-Oncogene Proteins/biosynthesis , Animals , Fluorescent Antibody Technique, Indirect , Infarction, Middle Cerebral Artery/enzymology , Male , Protein Serine-Threonine Kinases/biosynthesis , Protein-Tyrosine Kinases/biosynthesis , Proto-Oncogene Proteins c-akt , Rats , Rats, Wistar
7.
Hepatogastroenterology ; 46(27): 1774-7, 1999.
Article in English | MEDLINE | ID: mdl-10430342

ABSTRACT

With increasing evidence on the role of endogenous nitric oxide in the splanchnic hyperdynamics, the existence of esophageal varix induced by hepatopetal flow of portal hypertension in a cirrhotic patient has become more convincing. Herein, we report 2 cases of esophageal varix caused by local hyperdynamic states of the right, left and posterior gastric arteries, respectively. Angiographic evidence suggests the existence of forward flows via the submucosal A-V shunt of the gastric arteries as the etiologic causes of the varices. The treatment of the current cases was unsatisfactory due to improper recognition of the local hyperdynamic state before the treatment. Unlike the "backward flow"-type esophageal varix, the treatment strategies of the "forward flow"-type esophageal varix of hyperdynamic state caused by splanchnic A-V shunts should be considered differently.


Subject(s)
Arteriovenous Fistula/complications , Esophageal and Gastric Varices/etiology , Stomach/blood supply , Aged , Angiography , Arteries/physiopathology , Arteriovenous Fistula/diagnostic imaging , Arteriovenous Fistula/therapy , Carcinoma, Hepatocellular/complications , Carcinoma, Hepatocellular/diagnostic imaging , Carcinoma, Hepatocellular/therapy , Embolization, Therapeutic , Esophageal and Gastric Varices/diagnostic imaging , Esophageal and Gastric Varices/therapy , Female , Humans , Liver Cirrhosis/complications , Liver Cirrhosis/diagnostic imaging , Liver Cirrhosis/therapy , Liver Neoplasms/complications , Liver Neoplasms/diagnostic imaging , Liver Neoplasms/therapy , Male , Middle Aged , Sclerotherapy , Splanchnic Circulation/physiology , Treatment Failure
8.
Brain Res ; 834(1-2): 190-5, 1999 Jul 10.
Article in English | MEDLINE | ID: mdl-10407114

ABSTRACT

In an attempt to elucidate whether glial cell line-derived neurotrophic factor (GDNF) receptors are induced after ischemic brain injury, possible expression of immunoreactive GDNF receptor-alpha1 (GFRalpha-1) and c-ret (RET) was examined at 3, 8, or 24 h after permanent middle cerebral artery occlusion (MCAO) in rats. Immunohistochemical study showed that both GFRalpha-1 and RET staining cells which were not detected in sham control brain, were present in the ipsilateral cortex and caudate at 3 to 8 h after permanent MCAO, and then decreased but remained to some extent at 24 h. Positive cells for both GDNF receptors were predominantly in cortical neurons of ischemic penumbral area. Western blot analysis confirmed the induction of those receptors after permanent MCAO. This rapid induction of GFRalpha-1 and RET, which correlates with the similar induction of GDNF under these conditions, may play a role in the early response to ischemic brain injury.


Subject(s)
Arterial Occlusive Diseases/metabolism , Cerebral Arteries , Cerebral Cortex/metabolism , Corpus Striatum/metabolism , Drosophila Proteins , Proto-Oncogene Proteins/metabolism , Receptor Protein-Tyrosine Kinases/metabolism , Animals , Blotting, Western , Glial Cell Line-Derived Neurotrophic Factor Receptors , Immunohistochemistry/methods , Male , Proto-Oncogene Proteins c-ret , Rats , Rats, Wistar , Staining and Labeling , Time Factors
9.
Eur Surg Res ; 31(1): 48-56, 1999.
Article in English | MEDLINE | ID: mdl-10072610

ABSTRACT

The present study was designed to elucidate the effectiveness of portal decompression and FK506 (FK) pretreatment in extended hepatectomy in dogs. In the first set of experiment the effect of portal decompression was evaluated in two groups of dogs which underwent extended hepatectomies (80%) with or without (control) a side-to-side portacaval shunt. The presence of the shunt significantly (p < 0.05) improved the 7-day survival of the animals (57.1%) when compared with those of the control group (28.6%) and eventually the portal pressure was significantly lower and mean arterial pressure was significantly higher in the shunt group (p < 0. 05). Moreover, the animals with lower portal pressure (

Subject(s)
Hepatectomy , Liver Regeneration/drug effects , Liver Regeneration/physiology , Portacaval Shunt, Surgical , Tacrolimus/therapeutic use , Animals , Carcinoma, Hepatocellular/drug therapy , Carcinoma, Hepatocellular/surgery , Dogs , Female , Humans , Hypertension, Portal/surgery , Liver Neoplasms/drug therapy , Liver Neoplasms/surgery , Male
10.
Exp Cell Res ; 246(2): 412-20, 1999 Feb 01.
Article in English | MEDLINE | ID: mdl-9925757

ABSTRACT

The growth rate of tumors should be assessed in terms of both tumor cell proliferation and death. The former is considered to be determined by growth fraction and cell-cycle time, whereas the latter is mainly determined by apoptosis, especially in tumors with a low level of necrosis. While most hepatocellular carcinomas (HCCs) in a relatively early stage contain only a small amount of necrosis, the growth rate supposedly depends mainly on growth fraction, cell-cycle time, and apoptosis. However, their quantitative relationship remains unknown. We have derived a novel theoretical formula for determining this relationship in nonnecrotic HCC, using Ki-67-positive index, apoptotic score, and a correction factor, all calculable by histological assessment without injecting labeling agents. Furthermore, we confirmed the reliability of this formula, using a xenograft model of human HCC with less than 15% necrosis. In this model the values of cell-cycle time calculated from the formula were very close to those estimated by a conventional double-labeling method and showed high correlations. Since our novel formula can clarify the cell kinetics without cumbersome labeling procedures, it is expected to be clinically applicable to HCC with a small portion of necrosis, using the radiographically measured growth rate and the histologically assessed cell kinetic parameters.


Subject(s)
Carcinoma, Hepatocellular/pathology , Liver Neoplasms/pathology , Animals , Bromodeoxyuridine/immunology , Humans , Idoxuridine/immunology , Kinetics , Male , Mice , Mice, Inbred BALB C , Neoplasm Transplantation , Transplantation, Heterologous , Tumor Cells, Cultured
11.
Metab Brain Dis ; 13(3): 211-23, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9804366

ABSTRACT

A replication defective adenoviral vector containing the E. coli lacZ gene (AdCMVnLacZ) was directly injected into right hippocampus and lateral ventricle immediately after 5 min of transient global ischemia in gerbils. The relations between the lacZ gene expression and DNA fragmentation or heat shock protein 72 (HSP72) immunoreactivity were examined up to 21 days post ischemia. The lacZ gene was transiently expressed at 1 day in the hippocampus except around the CA1 region, while a large number of the periventricular cells strongly expressed the lacZ gene from 8 h to 7 days. In CA1 layer, terminal deoxynucleotidyl dUTP nick end labeling (TUNEL) positive cells, which were present only adjacent to the needle track at 8 h to 1 day, became more extensive in the whole CA1 layer at 3 to 7 days. TUNEL-positive cells were also detected around the DG at 1 day, around the needle track at 8 h to 3 days, and in the choroid plexus cells at 7 days. HSP72 staining was detected in the subiculum at 1 to 3 days, the dentate granule cells at 8 h to 1 day, and in the CA3 or CA4 pyramidal cells at 1 to 3 days. Some lacZ expressing cells were double-positive with HSP72 in DG, while the majority of those were distinguished from the TUNEL-positive cells. Pyramidal neurons were almost completely lost in the CA1 sector at 7 days after the ischemia. The present study demonstrates the successful LacZ gene transfer into the hippocampus and ventricle of postischemic gerbil brain except in the vulnerable CA1 layer by adenoviral vector injection. However, adenovirus-mediated gene transfer may induce indirect apoptotic cell death in the DG and ventricle, in addition to direct traumatic injury around the needle track.


Subject(s)
Adenoviridae , Brain Ischemia/physiopathology , Cerebral Ventricles/pathology , Gene Transfer Techniques , Heat-Shock Proteins/genetics , Hippocampus/pathology , Animals , Antibodies , Apoptosis/physiology , Biomarkers , Brain Ischemia/genetics , Cerebral Ventricles/blood supply , Cerebral Ventricles/chemistry , DNA Fragmentation , Gene Expression , Gerbillinae , HSP72 Heat-Shock Proteins , Heat-Shock Proteins/analysis , Heat-Shock Proteins/immunology , Hippocampus/blood supply , Hippocampus/chemistry , In Situ Nick-End Labeling , Lac Operon , Male
12.
J Neurosci Res ; 54(1): 38-45, 1998 Oct 01.
Article in English | MEDLINE | ID: mdl-9778148

ABSTRACT

Foreign genes have been successfully transferred and expressed in experimental animal brains using adenoviral vectors. However, it is not fully understood whether adenovirus-mediated gene transfer causes stressful or cytotoxic injury in brain. A replication-defective adenoviral vector containing the Escherichia coli lacZ gene (AdCMVnLacZ) was directly injected into right hippocampus and lateral ventricle of normal gerbil brains. Temporal and spatial profiles of the expression of lacZ gene products, DNA fragmentation detected by terminal deoxynucleotidyl d-UTP nick end labeling (TUNEL) staining, and heat shock protein 72 (HSP72) immunoreactivity were examined until 21 days after the injection. In the ventricle, lacZ gene was immediately and strongly expressed at 8 hr after the injection of AdCMVnLacZ, with a peak at 1-3 days, and disappeared by 21 days. Although a small number of choroid plexus cells were TUNEL positive at 3 and 7 days, no HSP72 immunostaining was observed in the ventricle. Small-to-moderate expression of lacZ gene was found in the needle route from 8 hr to 3 days after the injection, and a small number of TUNEL-positive cells were detected at the needle track at 1-3 days. In the hippocampus, lacZ gene was markedly expressed around the dentate gyrus (DG) at 8 hr to 3 days with a peak at 1 day. Large number of TUNEL or moderate-to-dense HSP70 staining cells were also detected in the same area. CA1 neuronal cells just adjacent to the needle route showed TUNEL positivity at 1 to 3 days. However, the TUNEL staining was not associated with lacZ gene expression. The majority of lacZ-expressing cells were discriminated from the TUNEL-positive cells, whereas some were double-positive with HSP72 staining in DG. Cellular loss was observed in the CA1 layer around the needle route. An apoptotic change was morphologically observed in the marginal region of the DG at 1-3 days and in the ventricle at 3-7 days. In the sham control group, TUNEL-positive or HSP72-staining cells were only detected around the needle track including CA1 cells adjacent to the needle route. These data suggest that adenoviral gene transfer may induce direct traumatic injury in the CA1 sector near the needle route, indirect apoptotic cell loss in the DG and ventricle, and stressful effect on the dentate granule cells in association with adenovirus infection in normal gerbil brain.


Subject(s)
Adenoviridae/genetics , Cerebral Ventricles/physiology , DNA Fragmentation , Gene Transfer Techniques , Heat-Shock Proteins/analysis , Hippocampus/physiology , Animals , Animals, Inbred Strains , Apoptosis , Cerebral Ventricles/cytology , Cerebral Ventricles/virology , Dentate Gyrus/metabolism , Genes, Reporter , Genetic Vectors , Gerbillinae , HSP72 Heat-Shock Proteins , Heat-Shock Proteins/immunology , Hippocampus/cytology , Hippocampus/virology , Immunohistochemistry , In Situ Nick-End Labeling , Injections , Injections, Intraventricular , Lac Operon , Male , Neurons/metabolism
13.
Biochem Biophys Res Commun ; 248(3): 660-3, 1998 Jul 30.
Article in English | MEDLINE | ID: mdl-9703982

ABSTRACT

The spontaneous recovery of nigrostriatal dopaminergic neurons was quantitatively analyzed with tyrosine hydroxylase (TH)-immunocytochemistry in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated C57BL/6 young mice. A substantial reduction of striatal dopamine (DA) level was observed until 24 days following MPTP treatment. The TH-immunoreactive (IR) fibers and number of TH-positive cell bodies were also markedly reduced at 3 days after the toxin treatment. Thereafter, TH-IR fiber densities showed to progressively recover through the examining period. The number of TH-positive cell bodies in substantia nigra pars compacta were not changed during the recovery period. These results indicate that MPTP-treated mice have a potential for spontaneous regenerative sprouting in nigrostriatal dopaminergic system.


Subject(s)
Corpus Striatum/physiology , Dopamine/metabolism , MPTP Poisoning , Nerve Regeneration , Neurons/physiology , Substantia Nigra/physiology , 3,4-Dihydroxyphenylacetic Acid/metabolism , Animals , Corpus Striatum/drug effects , Corpus Striatum/pathology , Homovanillic Acid/metabolism , Male , Mice , Mice, Inbred C57BL , Neurons/drug effects , Neurons/pathology , Substantia Nigra/drug effects , Substantia Nigra/pathology , Time Factors , Tyrosine 3-Monooxygenase/metabolism
14.
Stroke ; 29(7): 1417-22, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9660398

ABSTRACT

BACKGROUND AND PURPOSE: Glial cell line-derived neurotrophic factor (GDNF) plays important roles in the survival and recovery of some mature neurons under pathological conditions. However, the effect of GDNF in ameliorating ischemic brain injury has not been well documented. Therefore, we investigated a possible effect of GDNF on the changes of infarct size, brain edema, DNA fragmentation, and immunoreactivities for caspases after permanent middle cerebral artery occlusion (MCAO) in rats. METHODS: For the estimation of ischemic brain injury, we calculated the infarct size of MCA region and also measured the brain water content as edema formation at 24 hours after the MCAO. Terminal deoxynucleotidyl transferase-mediated dUTP-biotin in situ nick labeling (TUNEL) staining was performed for the detection of DNA fragmentation. Immunoreactivities for caspase-1 (ICE), caspase-2 (Nedd-2), and caspase-3 (CPP32) were stained. RESULTS: Both infarct size and brain edema after permanent MCAO were significantly reduced by topical application of GDNF (48% and 30% decreases, P=0.01). TUNEL staining and immunoreactivities for caspases were markedly induced at 12 hours after permanent MCAO in the vehicle-treated animals. However, the spatial distribution of those immunohistochemically positive cells was dissociative in each caspase. Induction of TUNEL staining and immunoreactivities for caspases-1 and -3 was greatly reduced with GDNF treatment, whereas the reduction of caspase-2 staining was only minimum. CONCLUSIONS: These data suggest that the reduction of infarct size and brain edema by GDNF was greatly associated with the reduction of DNA fragmentation and apoptotic signals predominantly through caspases-1 and -3 cascades.


Subject(s)
Arterial Occlusive Diseases/complications , Brain Ischemia/etiology , Brain Ischemia/pathology , Nerve Growth Factors , Nerve Tissue Proteins/pharmacology , Neuroprotective Agents/pharmacology , Administration, Topical , Animals , Body Water/metabolism , Brain/enzymology , Brain Edema/metabolism , Cerebral Arteries , Cerebral Infarction/pathology , Cysteine Endopeptidases/metabolism , DNA Fragmentation/drug effects , Genetic Techniques , Glial Cell Line-Derived Neurotrophic Factor , Immunohistochemistry , Male , Rats , Rats, Wistar
15.
Neurol Res ; 20(4): 333-6, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9618697

ABSTRACT

Glial cell line-derived neurotrophic factor (GDNF) was applied topically on the brain surface immediately after permanent middle cerebral artery (MCA) occlusion in rats. In contrast to the cases treated with vehicle, a formation of brain edema was significantly reduced at one day by the treatment with GDNF. Terminal deoxynucleotidyl transferase-mediated dUTP-biotin in situ nick end labeling (TUNEL) staining was markedly reduced in the cases with GDNF treatment at 12 h after MCA occlusion. However, the induction of immunoreactive 70-kd heat shock protein (HSP70) was slightly ameliorated by the GDNF treatment. The present results suggest that the treatment with GDNF has a significant effect on ameliorating brain edema formation after continuous brain ischemia, and the effect is greatly associated with the reduction of apoptotic changes, but slightly with that of stress response of cells.


Subject(s)
Arterial Occlusive Diseases/drug therapy , Brain Edema/prevention & control , Cerebral Arteries , Nerve Growth Factors , Nerve Tissue Proteins/therapeutic use , Neuroprotective Agents/therapeutic use , Administration, Topical , Animals , Brain/metabolism , Cerebral Arteries/drug effects , Genetic Techniques , Glial Cell Line-Derived Neurotrophic Factor , HSP70 Heat-Shock Proteins/antagonists & inhibitors , HSP70 Heat-Shock Proteins/metabolism , Immunologic Techniques , Male , Nerve Tissue Proteins/administration & dosage , Neuroprotective Agents/administration & dosage , Rats , Staining and Labeling
16.
Biochem Biophys Res Commun ; 245(2): 378-81, 1998 Apr 17.
Article in English | MEDLINE | ID: mdl-9571158

ABSTRACT

Otsuka Long-Evans Tokushima Fatty (OLETF) rats showed that the distribution of plasma membrane content of insulin-regulated glucose transporter in skeletal muscle was reminiscent of that in human non-insulin-dependent diabetes mellitus (NIDDM). To obtain more information on the cellular mechanisms of muscle insulin resistance, hexokinase activities were measured in the skeletal muscle of OLETF rats. The results showed that the activity of the type II enzyme in the diabetic rats was significantly decreased (P < 0.05) compared with Long-Evans Tokushima Otsuka (LETO) control rats. No significant differences in the activity of the type I hexokinase were observed between these rats. Western blot analysis showed that the protein content of the type II in OLETF rats was also significantly lower than that in LETO rats (P < 0.05). After insulin stimulation, the intramuscular content of glucose 6-phosphate, which regulates glycogen synthesis in skeletal muscle, was significantly decreased in OLETF rats (P < 0.01). However, glycogen synthase activity in vitro and intramuscular lactate concentration in these rats did not show significant differences. These results suggest that the G6P content of the diabetic rats is decreased as a result of an impaired early event of glucose metabolism, indicating that the molecular defects of skeletal muscle in OLETF rats are similar to those in NIDDM patients.


Subject(s)
Diabetes Mellitus, Type 2/metabolism , Disease Models, Animal , Glucose/metabolism , Muscle, Skeletal/enzymology , Animals , Glucose-6-Phosphate/metabolism , Glycogen Synthase/metabolism , Hexokinase/analysis , Hyperinsulinism/pathology , Insulin/pharmacology , Insulin Resistance/physiology , Isoenzymes/analysis , Lactic Acid/analysis , Monosaccharide Transport Proteins/metabolism , Rats , Rats, Inbred Strains
17.
J Biol Chem ; 270(42): 24678-81, 1995 Oct 20.
Article in English | MEDLINE | ID: mdl-7559581

ABSTRACT

Insulin binding results in rapid phosphorylation of insulin receptor substrate-1 to activate p21ras and mitogen-activated protein kinase. Insulin also activates the ribosomal protein S6 kinase (pp70 S6 kinase) independently of the Ras pathway. Chronic (18 h) treatment of L6 muscle cells with insulin increases glucose transport activity severalfold due to biosynthetic elevation of the GLUT1 and GLUT3 but not the GLUT4 glucose transporters. Here we investigate the roles of p21ras and pp70 S6 kinase in the insulin-mediated increases in GLUT1 and GLUT3 expression. L6 cells were transfected with the dominant negative Ras(S17N) under the control of a dexamethasone-inducible promoter. Induction of Ras(S17N) failed to block the insulin-mediated increase in GLUT1 glucose transporter protein and mRNA; however, it abrogated the insulin-mediated increase in GLUT3 glucose transporter protein and mRNA. Inhibition of pp70 S6 kinase by rapamycin, on the other hand, eliminated the insulin-mediated increase in GLUT1 but had no effect on that of GLUT3 in both parental and Ras(S17N) transfected L6 cells. These results suggest that the biosynthetic regulation of glucose transporters is differentially determined, with pp70 S6 kinase and p21ras playing active roles in the insulin-stimulated increases in GLUT1 and GLUT3, respectively.


Subject(s)
Insulin/pharmacology , Monosaccharide Transport Proteins/biosynthesis , Muscle, Skeletal/metabolism , Nerve Tissue Proteins , Animals , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Cell Line , Dexamethasone/pharmacology , Glucose Transporter Type 1 , Glucose Transporter Type 3 , Phosphorylation , Polyenes/pharmacology , Protein Serine-Threonine Kinases/physiology , Proto-Oncogene Proteins p21(ras)/physiology , Rats , Ribosomal Protein S6 Kinases , Sirolimus
18.
FEBS Lett ; 368(1): 19-22, 1995 Jul 10.
Article in English | MEDLINE | ID: mdl-7615080

ABSTRACT

The effects of insulin and IGF-I on the cell surface quantities of GLUT1, GLUT3 and GLUT4 glucose transporters in L6 myotubes were determined with the exofacial bis-mannose phololabel (ATB-BMPA). In basal cells, an equal molar quantity of each transporter isoform was found at the cell surface. Insulin stimulated the translocation of all three glucose transporter isoforms to the plasma membrane fraction from the light microsome fraction, resulting in equal molar quantities on the cell surface. IGF-I stimulated a similar translocation of all isoforms, augmented by an increase in surface GLUT3 as assessed by ATB-BMPA.


Subject(s)
Glucose/metabolism , Insulin-Like Growth Factor I/metabolism , Insulin/metabolism , Monosaccharide Transport Proteins/metabolism , Muscle Proteins , Muscle, Skeletal/metabolism , Nerve Tissue Proteins , Propylamines , Affinity Labels , Animals , Azides , Cell Line , Cell Membrane/metabolism , Disaccharides , Glucose Transporter Type 1 , Glucose Transporter Type 3 , Glucose Transporter Type 4 , Glycosides , Humans , Mice
19.
Biochem J ; 304 ( Pt 1): 139-45, 1994 Nov 15.
Article in English | MEDLINE | ID: mdl-7998925

ABSTRACT

Molecular studies have identified a family of synaptic vesicle-associated membrane proteins (VAMPs, also known as synaptobrevins) which have been implicated in synaptic vesicle docking and/or fusion with plasma membrane proteins. Here we demonstrate the expression of two members of this family, VAMP-2/synaptobrevin II and cellubrevin, in skeletal muscle, a tissue with both constitutive and regulated membrane traffic. The 18 kDa VAMP-2 polypeptide was detected in purified membrane fractions from adult skeletal muscle and from L6 myotubes in culture, demonstrating that the presence of this protein in the isolated muscle membrane fractions is not the result of contamination by ancillary tissues such as peripheral nerve. Furthermore, skeletal muscle and the muscle cell line also expressed cellubrevin, a VAMP-2 homologue of 17 kDa; which is much less abundant in brain cells. Both VAMP-2 and cellubrevin were preferentially isolated in membrane fractions rich in plasma membranes, and were less concentrated in light microsomes and other internal membrane fractions of mature muscle or muscle cells in culture. Interestingly, both VAMP-2 and cellubrevin were much more abundant in the differentiated L6 myotubes than in their precursor myoblasts, suggesting that they are required for functions of differentiated muscle cells. The identity of both polypeptides was further confirmed by their susceptibility to proteolysis by Clostridium tetanus toxin. Expression of these products was further established by the presence of mRNA transcripts of VAMP-2 and cellubrevin, but not of VAMP-1, in both skeletal muscle and L6 myotubes. In contrast, other synaptic vesicle and docking/fusion components were undetectable, such as VAMP-1, SNAP25 and syntaxin 1A/1B, as were synaptophysin and synapsin Ia/Ib, proteins which are believed to be involved in sensing the signal for neuronal exocytosis. It is concluded that VAMP-2 and cellubrevin are expressed in skeletal muscle cells and may each participate in specific processes of intracellular membrane traffic.


Subject(s)
Membrane Proteins/biosynthesis , Muscle, Skeletal/metabolism , Nerve Tissue Proteins/biosynthesis , Amino Acid Sequence , Animals , Antibodies , Blotting, Northern , Cell Line , Membrane Proteins/immunology , Molecular Sequence Data , Nerve Tissue Proteins/immunology , R-SNARE Proteins , RNA, Messenger/analysis , Rats , Vesicle-Associated Membrane Protein 3
20.
Mol Membr Biol ; 11(4): 255-62, 1994.
Article in English | MEDLINE | ID: mdl-7711835

ABSTRACT

The expression of Na,K-ATPase isoforms was investigated in human skeletal muscle membranes isolated by subcellular fractionation. The alpha 1, alpha 2, alpha 3 and beta 1 subunits were detectable in membranes prepared from the human soleus muscle. The alpha 1 subunit was largely detected in a fraction enriched with plasma membranes (PM), its abundance in an intracellular membrane fraction (IM) accounted for only 4% of that in the PM fraction. No alpha 1 subunits were detected in membranes of sarcoplasmic reticulum (SR) origin. The PM and IM fractions were enriched with alpha 2 subunits which were less abundant in the SR-enriched fraction. The abundance of alpha 2 molecules within the IM fraction was about 75% of that in the PM fraction when the total protein content for the two fractions was taken into account. Immunocytochemical studies confirmed the localization of the alpha 1 subunit to the muscle cell surface. The alpha 2 subunit was also found to be present in the cell surface but the observation that alpha 2 immunofluorescence was diffusely dispersed throughout the muscle fibre indicated that it was also present intracellularly, consistent with its biochemical localization in the PM and IM membrane fractions. The alpha 3 subunit was detected largely in the PM fraction but the lack of good antibodies to this isoform precluded an analysis of its immunocytochemical localization. The beta 1 subunit was enriched in the PM fraction but was also detected to a modest extent in the IM.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Isoenzymes/analysis , Muscle, Skeletal/enzymology , Sodium-Potassium-Exchanging ATPase/analysis , Antibodies , Antibody Specificity , Humans , Immunoblotting , Immunohistochemistry , Isoenzymes/immunology , Macromolecular Substances , Membranes/chemistry , Membranes/enzymology , Muscle, Skeletal/chemistry , Sodium-Potassium-Exchanging ATPase/immunology , Subcellular Fractions/chemistry , Subcellular Fractions/enzymology
SELECTION OF CITATIONS
SEARCH DETAIL
...